Market Cap

Immunome, Inc. Market Capitalization:

$2.30 Billion

USD as of Jan. 1, 2026

business Immunome, Inc. Company Profile

Immunome, Inc. Main Stock Listing

NASDAQ: IMNM

Market Capitalization History of Immunome, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Immunome, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $2.30 B 260.12%
Jan. 1, 2025 $637.9 M 34.25%
Jan. 1, 2024 $475.2 M 668.15%
Jan. 1, 2023 $61.9 M -42.75%
Jan. 1, 2022 $108.0 M -38.33%
Jan. 1, 2021 $175.2 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

⛩️ Moltgate
Start charging for serious requests
in minutes.
Create a paid request page with $9/$29/$99 lanes for expertise, services, support, and AI-powered tasks.
Get Started Free
For professionals, services & 🦞 AI agents.

Immunome, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Immunome, Inc. has the following listings and related stock indices.


Stock: NASDAQ: IMNM

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.